Earlier studies emphasizing a beneficial role of diet supplementation with DHA indicate hepatic SREBP-1c as the major target in the control of hepatic lipogenesis and development of fatty liver (33, 34). This evidence concerns the gene SREBF1 and fatty liver disease.